Glenmark Pharma hits over 7-year low after Q1 profit misses estimates

Reuters | Updated on August 14, 2019 Published on August 14, 2019

Shares of Glenmark Pharmaceuticals Ltd fall as much as 7.24% to Rs 385.5, their lowest since August 3, 2012

The pharma major posts a 53% drop in June quarter profit to Rs 109 crore ($15.37 mln) against Rs 233 crore in the corresponding quarter last year, impacted due to moderate performance in the US and subdued performance in Latin America

Total expenses had risen 9.5% to Rs 1,977 crore

The first quarter profit misses estimates of Rs 182 crore.

Up to last close, Glenmark has lost 40% this year, while Sun Pharmaceutical, which posted a 31% jump in Q1 profit on Tuesday, is up 2%

Published on August 14, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.